Roche Corleen M. bought IOVA
November 6, 2026 · Form 4 insider transaction
Roche Corleen M. bought 12,500 shares of Iovance Biotherapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
12,500
Price
$0.00
Total value
N/A
InsiderRoche Corleen M.
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateNovember 6, 2026
Filing dateNovember 10, 2026
Shares owned after41,257
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.